Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV‐1 infection: results from a longitudinal study in the French ANRS Primo cohort
Authors:
- Sophie NovelliSNSophie Novelli
- Pierre DelobelPDPierre Delobel
- Olivier BouchaudOBOlivier Bouchaud
- Véronique Avettand‐FenoelVAVéronique Avettand‐Fenoel
- Pascale FialairePFPascale Fialaire
- André CabiéACAndré Cabié
- Faouzi SoualaFSFaouzi Souala
- François RaffiFRFrançois Raffi
- Pilartxo CatalanPCPilartxo Catalan
- Laurence WeissLWLaurence Weiss
- Laurence MeyerLMLaurence Meyer
- Cécile GoujardCGCécile Goujard
Open Access
- 25 April 2020
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 23 (4) , e25485
Abstract
Introduction: Previous studies have reported better immunovirological characteristics in women compared with men after HIV seroconversion. We investigated whether differences persisted under long‐term antiretroviral therapy (ART) in individuals treated since acute and early HIV‐1 infection (AHI).Methods: Data were obtained for 262 women and 1783 men enrolled between 1996 and 2017 in the French multicentre ANRS PRIMO cohort. We modelled the viral response, long‐term immune recovery and HIV DNA decay in the 143 women and 1126 men who initiated ART within the first three months of infection.Results: The participants were mostly white. The mean age was 37 years at AHI diagnosis. Pre‐ART viral loads were lower in women than men, 5.2 and 5.6 log10 copies/mL (p = 0.001). After ART initiation, women more rapidly achieved viral suppression than men (adjusted hazard ratio: 1.33, 95% confidence interval 1.09 to 1.69). They also experienced a faster increase in CD4+ T‐cell count and CD4:CD8 ratio during the first months of treatment. Sex‐related differences in CD4+ T‐cell counts were more pronounced with increasing age. This led to a sustained mean difference of 99 to 168 CD4+ T‐cells/µL depending on age between women and men at 150 months of ART. Moreover, CD4:CD8 ratio of women was higher than that of men by 0.31, at 150 months of ART. There was no statistically significant difference between sexes for the levels of HIV DNA over time (mean estimate at the last modelling point: 1.9 log10 copies/106 PBMCs after 70 months of ART for both sexes).Conclusions: The high level of immune recovery and decrease in total HIV DNA levels achieved after ART initiation during AHI reinforce the importance of early diagnosis of HIV infection and immediate ART initiation. The immunological benefit of being female increased throughout prolonged ART duration, which may give women additional protection from adverse clinical events and premature ageing.Keywords
Funding Information
- Université Paris-Saclay
This publication has 58 references indexed in Scilit:
- Population-Based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment CoveragePLOS ONE, 2013
- Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral TherapyNew England Journal of Medicine, 2013
- Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort studyBMC Infectious Diseases, 2012
- Outcomes in the First Year after Initiation of First-Line Haart among Heterosexual Men and Women in the Uk Chic StudyAntiviral Therapy, 2011
- Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 InfectionThe Journal of Infectious Diseases, 2011
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1Nature Medicine, 2009
- Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in WomenAmerican Journal of Epidemiology, 2008
- Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewJournal of Antimicrobial Chemotherapy, 2007
- Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment responseHIV Medicine, 2006
- Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.Sexually Transmitted Infections, 1996